Another gene expression data set of 42 melanoma patients treated with anti-CTLA4 was reported in Van Allen et al.1 Our scores are significantly associated with response (p value: 0.009) as well as overall survival (p value: 0.013 Cox proportional hazard) and AUC 0.72 (Fig. 5c). This evidence concerns the gene CTLA4 and melanoma.